Bioharvest Sciences (BHST) Accounts Payables (2023 - 2025)

Bioharvest Sciences' Accounts Payables history runs 3 years deep, the most recent figure standing at $2.2 million for Q4 2025.

• On a quarterly basis, Accounts Payables fell 39.79% year-over-year to $2.2 million in Q4 2025; TTM through Dec 2025 was $2.2 million, a 39.79% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 39.79% from the prior year.
• Accounts Payables retreated to $2.2 million in Q4 2025 per BHST's latest filing, from $3.5 million in the prior quarter.
• Across five years, Accounts Payables topped out at $4.4 million in Q3 2024 and bottomed at $1.8 million in Q4 2023.
• The 3-year median for Accounts Payables is $3.5 million (2024), against an average of $3.4 million.
• Across the five-year window, Accounts Payables jumped 102.98% in 2024 and tumbled 39.79% in 2025, its largest moves.
• Year by year, Accounts Payables stood at $1.8 million in 2023, then soared by 102.98% to $3.6 million in 2024, then tumbled by 39.79% to $2.2 million in 2025.
• Per Business Quant, the three latest BHST Accounts Payables figures stand at $2.2 million (Q4 2025), $3.5 million (Q3 2025), and $3.4 million (Q2 2025).